Endogenous cortisol 6 beta-hydroxylation clearance is not an accurate probe for overall cytochrome P450 3A phenotyping in humans.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Clinica chimica acta; international journal of clinical chemistry

• Publication date

  2009-10-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.cca.2009.07.017PMID 19654004
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Probe of CYP3A by a single-point blood measurement after oral administration of midazolam in healthy elderly volunteers

  2006cited by this paper
• Limited Sampling Models for Oral Midazolam: Midazolam Plasma Concentrations, Not the Ratio of 1‐Hydroxymidazolam to Midazolam Plasma Concentrations, Accurately Predicts AUC as a Biomarker of CYP3A Activity

  2006cited by this paper
• Poor correlation between 6beta-hydroxycortisol:cortisol molar ratios and midazolam clearance as measure of hepatic CYP3A activity.

  2006cited by this paper
• Simultaneous determination of 6beta-hydroxycortisol and cortisol in human urine and plasma by liquid chromatography with ultraviolet absorbance detection for phenotyping the CYP3A activity.

  2005cited by this paper
• Cytochrome P450 3A: genetic polymorphisms and inter-ethnic differences.

  2005cited by this paper
• Cytochrome P450 3A: genetic polymorphisms and inter-ethnic differences.

  2005cited by this paper
• Oral administration of a low dose of midazolam (75 microg) as an in vivo probe for CYP3A activity.

  2004cited by this paper
• Oral administration of a low dose of midazolam (75 μg) as an in vivo probe for CYP3A activity

  2004cited by this paper
• Sensitive determination of midazolam and 1'-hydroxymidazolam in plasma by liquid-liquid extraction and column-switching liquid chromatography with ultraviolet absorbance detection and its application for measuring CYP3A activity.

  2004cited by this paper
• In vivo comparisons of constitutive cytochrome P450 3A activity assessed by alprazolam, triazolam, and midazolam

  2004cited by this paper
• Evidence for the validity of cortisol 6 beta-hydroxylation clearance as a new index for in vivo cytochrome P450 3A phenotyping in humans.

  2003cited by this paper
• Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.

  2003cited by this paper
• Cytochrome P450 in vitro reaction phenotyping: a re-evaluation of approaches used for P450 isoform identification.

  2003cited by this paper
• Midazolam Exhibits Characteristics of a Highly Permeable P-Glycoprotein Substrate

  2003cited by this paper
• Urinary 6β-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals

  2003cited by this paper
• Cytochrome P450 Phenotyping/Genotyping in Patients Receiving Antipsychotics

  2002cited by this paper
• Sex‐related differences in the clearance of cytochrome P450 3A4 substrates may be caused by P‐glycoprotein

  2002cited by this paper
• Limited Sampling Strategy to Predict AUC of the CYP3A Phenotyping Probe Midazolam in Adults: Application to Various Assay Techniques

  2002cited by this paper
• In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration.

  2001cited by this paper
• Midazolam and cortisol metabolism before and after CYP3A induction in humans.

  2001cited by this paper
• Single plasma sampling to predict oral clearance of CYP3A probe midazolam.

  2001cited by this paper
• Problems and perspectives of phenotyping for drug-metabolizing enzymes in man.

  2000cited by this paper
• Phenotyping of drug-metabolizing enzymes in adults: a review of in-vivo cytochrome P450 phenotyping probes.

  2000cited by this paper
• Is selective reporting of clinical research unethical as well as unscientific

  1999cited by this paper
• Failure of erythromycin breath test to correlate with midazolam clearance as a probe of cytochrome P4503A

  1999cited by this paper
• The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin

  1998cited by this paper
• Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms.

  1995cited by this paper
• Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.

  1994cited by this paper
• Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.

  1994cited by this paper
• Absence of correlations among three putative in vivo probes of human cytochrome P4503A activity in young healthy men

  1993cited by this paper
• Comparison of urinary 6‐β‐cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activity

  1992cited by this paper
• Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone.

  1992cited by this paper
• Heterogeneity of CYP3A isoforms metabolizing erythromycin and cortisol

  1992cited by this paper

• Deconvoluting Gut Versus Liver Cytochrome P450 3A4 Function: Drug Probes, Biomarkers, and Tissue Biopsy

  2026cites this paper
• Novel Approaches to Characterize Individual Drug Metabolism and Advance Precision Medicine

  2023cites this paper
• Circulating Biomarkers Instead of Genotyping to Establish Metabolizer Phenotypes.

  2023cites this paper
• Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches

  2019cites this paper
• Interindividual Variability in Cytochrome P450–Mediated Drug Metabolism

  2016cites this paper
• Relationships between Endogenous Plasma Biomarkers of Constitutive Cytochrome P450 3A Activity and Single‐Time‐Point Oral Midazolam Microdose Phenotype in Healthy Subjects

  2016cites this paper
• Pharmacokinetic drug interactions involving Ginkgo biloba

  2013cites this paper
• Quantitation of Urinary 6ß-Hydroxycortisol and Free Cortisol by Ultra-Performance Liquid Chromatography-Quadrupole Time-of-Flight Mass Spectrometry

  2012cites this paper
• Sex-Dependent Differences in Cytochrome P450 3A Activity as Assessed by Midazolam Disposition in Humans: A Meta-Analysis

  2010cites this paper